Objective:To preliminarily explore the clinical value of quantitative parameters on dual-layer detector spectral CT in guiding immunotherapy for gastric cancer.Methods:The clinical and imaging data of 35 gastric cancer patients who underwent first-line chemotherapy combined with pro-grammed death-1(PD-1)inhibitors in our hospital from October 2021 to September 2023 were retro-spectively analyzed.Treatment responses were evaluated according to the modified response evaluation criteria in solid tumor(mRECIST)criteria,with complete response(CR)and partial response(PR)categorized as the responsive group,and stable disease(SD)and progression disease(PD)as the non-responsive group.All patients underwent plain scanning and dual-phase contrast-enhanced scanning at a spectral CT scanner within two weeks prior to treatment,with arterial phase and venous phase ima-ges obtained 30 seconds and 60 seconds after contrast injection,respectively.Quantitative parameters,including arterial and venous phase iodine concentration(IC),normalized iodine concentration(nIC),and Z-effective(Zeff),were measured from reconstructed images on the post-processing workstation.Clinical features and spectral parameters were compared between the two groups using independent sample t-test,Mann-Whitney U-test,or Fisher's exact test.Receiver operating characteristic(ROC)curves were plotted to evaluate the predictive efficacy of each parameter for immunotherapy response.Results:Arterial and venous phase IC,nIC,and Zeff in the responsive group were significantly lower than those in the non-responsive group(all P<0.05).The venous phase nIC achieved the highest area under the ROC curve(AUC)value for predicting immunotherapy response in gastric cancer,with a value of 0.798(95%CI:0.650~0.945).Using a cutoff value of 0.49,the accuracy was 71.4%,sensitivi-ty was 85.7%,and specificity was 61.9%.The AUC value of arterial phase nIC ranked second highest at 0.787(95%CI:0.631~0.944),with a cutoff value of 0.16.The corresponding accuracy was of 77.1%,sensitivity was 78.6%,and specificity was 76.2%.The difference in AUC values between nIC in venous phase and nIC in arterial phase was not statistically significant(Z=0.13,P=0.898).Conclu-sion:The nIC in arterial phase and venous phase measured by spectral CT demonstrated excellent pre-dictive efficacy for immunotherapy response in gastric cancer,suggesting their potential as biomarkers for reflecting the efficacy of immunotherapy.